Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma
Yusuke Mochizuki(Okayama University), Toshiyoshi Fujiwara(Okayama University), Toshiyuki Kunisada(Okayama University Hospital), Hiroya Kondo(National Cancer Centre Japan), Shunsuke Kagawa(Okayama University Hospital), Joe Hasei(Okayama University Hospital), Koji Demiya(Okayama University), Tadashi Komatsubara(Okayama University), Aki Yoshida(Okayama University), Miho Kure(Okayama University), Kazuhisa Sugiu(Okayama University), Toshifumi Ozaki(Okayama University), Yasuo Urata(Okayama University Hospital), Hiroshi Tazawa(Okayama University)
Cited by 29
Related Papers
Tumor-suppressive <i>miR-34a</i> induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
|Proceedings of the National Academy of Sciences|2007|902
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343
Osteosarcoma of the spine
|Cancer|2002|282
Percutaneous radiofrequency ablation in osteoid osteoma
|Journal of Bone and Joint Surgery - British Volume|2001|267